1ST Source Bank’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-3,298
| Closed | -$301K | – | 269 |
|
|
2021
Q2 | $301K | Sell |
3,298
-1,547
| -32% | -$138K | 0.02% | 216 |
|
|
2021
Q1 | $414K | Sell |
4,845
-19
| -0.4% | -$1.71K | 0.03% | 187 |
|
|
2020
Q4 | $460K | Hold |
4,864
| – | – | 0.03% | 172 |
|
|
2020
Q3 | $423K | Sell |
4,864
-2,868
| -37% | -$248K | 0.04% | 166 |
|
|
2020
Q2 | $675K | Sell |
7,732
-125
| -2% | -$10.8K | 0.06% | 137 |
|
|
2020
Q1 | $647K | Buy |
7,857
+446
| +6% | +$39.8K | 0.07% | 132 |
|
|
2019
Q4 | $702K | Buy |
7,411
+547
| +8% | +$49.1K | 0.05% | 140 |
|
|
2019
Q3 | $596K | Sell |
6,864
-192
| -3% | -$17.2K | 0.05% | 144 |
|
|
2019
Q2 | $644K | Sell |
7,056
-825
| -10% | -$69.8K | 0.05% | 137 |
|
|
2019
Q1 | $679K | Sell |
7,881
-259
| -3% | -$20.8K | 0.06% | 130 |
|
|
2018
Q4 | $626K | Sell |
8,140
-291
| -3% | -$22.7K | 0.06% | 125 |
|
|
2018
Q3 | $651K | Sell |
8,431
-17
| -0.2% | -$1.26K | 0.05% | 141 |
|
|
2018
Q2 | $572K | Buy |
8,448
+899
| +12% | +$62K | 0.05% | 144 |
|
|
2018
Q1 | $546K | Buy |
7,549
+66
| +0.9% | +$5.02K | 0.05% | 146 |
|
|
2017
Q4 | $563K | Sell |
7,483
-46
| -0.6% | -$3.47K | 0.05% | 145 |
|
|
2017
Q3 | $579K | Sell |
7,529
-36
| -0.5% | -$2.72K | 0.05% | 144 |
|
|
2017
Q2 | $566K | Sell |
7,565
-234
| -3% | -$16.6K | 0.05% | 148 |
|
|
2017
Q1 | $519K | Sell |
7,799
-100
| -1% | -$6.66K | 0.05% | 153 |
|
|
2016
Q4 | $515K | Sell |
7,899
-320
| -4% | -$20.8K | 0.05% | 151 |
|
|
2016
Q3 | $581K | Buy |
8,219
+2,100
| +34% | +$153K | 0.06% | 139 |
|
|
2016
Q2 | $452K | Buy |
6,119
+254
| +4% | +$17.5K | 0.05% | 160 |
|
|
2016
Q1 | $381K | Buy |
5,865
+122
| +2% | +$8.3K | 0.04% | 164 |
|
|
2015
Q4 | $442K | Buy |
5,743
+50
| +0.9% | +$3.97K | 0.05% | 158 |
|
|
2015
Q3 | $469K | Buy |
5,693
+239
| +4% | +$21.3K | 0.05% | 178 |
|
|
2015
Q2 | $481K | Buy |
5,454
+558
| +11% | +$51.2K | 0.05% | 165 |
|
|
2015
Q1 | $433K | Buy |
4,896
+65
| +1% | +$5.76K | 0.05% | 158 |
|
|
2014
Q4 | $402K | Buy |
4,831
+11
| +0.2% | +$912 | 0.05% | 161 |
|
|
2014
Q3 | $406K | Sell |
4,820
-30
| -0.6% | -$2.43K | 0.05% | 155 |
|
|
2014
Q2 | $394K | Buy |
+4,850
| New | +$381K | 0.05% | 156 |
|
Other funds holding NVS
1ST Source Bank's NVS Position: Q3 2021 in Review
1ST Source Bank sold out of Novartis (NVS) in Q3 2021, closing a stake of 3,298 shares — an estimated $301K sold.
1ST Source Bank first reported a position in NVS in Q2 2014 and held it in 29 quarters. The position peaked at $702K in Q4 2019. 1,080 funds tracked by Wall St. Rank hold NVS as of Q3 2021.
- 1ST Source Bank reported no remaining Novartis position as of Q3 2021 after selling out during the quarter.
- 1ST Source Bank sold 3,298 Novartis shares in Q3 2021, an estimated $301K.
- 1ST Source Bank first reported a position in Novartis in Q2 2014 and held it in 29 quarters.
- 1ST Source Bank's Novartis position peaked at $702K in Q4 2019.
- 1,080 funds tracked by Wall St. Rank held Novartis as of Q3 2021.
Based on 1ST Source Bank's 13F filing for Q3 2021, filed 5 Nov 2021.